SUPPOSITORIES WITH PUMPKIN SEED OIL

Ukraine

They are used for the complex treatment of prostatitis, as well as in the early stages of benign prostatic hyperplasia.

Brand name SUPPOSITORIES WITH PUMPKIN SEED OIL
Dosage form suppositories, rectal
Active substance / Dosage
Prescription type over-the-counter (OTC)
ATC code
Registration number UA/5990/01/01
Manufacturer PJSC "Monfarm"
SUPPOSITORIES WITH PUMPKIN SEED OIL suppositories, rectal

Frequently asked questions

How should Suppositories with pumpkin seed oil be taken correctly?

The drug is administered rectally. Adults should use 1 suppository 2 times a day. In the case of prostatitis, the treatment course is 1 month, and in the case of benign prostatic hyperplasia, it is 3 months.

What side effects may occur from taking the drug?

In some cases, digestive disorders (dyspepsia), infrequent bowel movements, or allergic reactions may occur. In case of overdose, diarrhea and lethargy are possible.

Who should not use this product?

The drug should not be used by children, nor by individuals with an individual hypersensitivity to its components.

Can the drug be taken during pregnancy or breastfeeding?

Suppositories with pumpkin seed oil are intended for adult men only.

Do these suppositories interact with other medicines?

Information regarding interactions with other medicinal products is currently unknown.

Instructions for use

INSTRUCTION
for medical use of medicinal product

RECTAL SUPPOSITORIES WITH PUMPKIN SEED OIL
(SUPPOSITORIA CUM OLEA SEMINIS CUCURBITAE)

Composition:

Active ingredient: 1 suppository contains pumpkin seed oil 0.5 g;

Excipients: hard fat.

Pharmaceutical form. Rectal suppositories.

Main physico-chemical properties: suppositories from light yellow with a greenish tint to green with a yellowish tint in color.

Pharmacotherapeutic group. Agents used in benign prostatic hyperplasia. ATC code G04C X.

Pharmacological properties.

Pharmacodynamics.

Pumpkin seed oil contained in the drug composition comprises fatty acids (palmitic, stearic, oleic, linoleic), sterins, phospholipids, carotenoids, vitamins and microelements. The drug reduces dysuric symptoms in prostatitis and benign prostatic hyperplasia, and exerts anti-inflammatory and analgesic effects.

Clinical characteristics.

Indications.

In the complex treatment of prostatitis of various etiologies. Initial stage of benign prostatic hyperplasia (as part of combination therapy).

Contraindications.

Individual hypersensitivity to the components of the drug.

Interaction with other medicinal products and other forms of interaction. Unknown.

Instructions for use.

Use during pregnancy or breastfeeding. Suppositories with pumpkin seed oil are intended for use in adult males only.

Ability to affect reaction speed when driving vehicles or operating machinery.

Not studied.

Method of administration and dosage.

Administer rectally. For adults: 1 suppository (0.5 g) twice daily. The daily therapeutic dose is 1 g (2 suppositories). Treatment duration: 1 month for prostatitis, 3 months for benign prostatic hyperplasia.

Children.

The drug must not be used in children.

Overdose.

Possible intensification of adverse reactions, diarrhea, lethargy.

Side effects.

In individual cases, dyspeptic symptoms, diarrhea, and allergic reactions are possible.

Shelf life.

2 years.

Storage conditions.

In the original packaging at a temperature not exceeding 15 °C. Keep out of reach of children.

Packaging.

5 suppositories per strip. 2 strips per carton.

Classification.

Over-the-counter (without prescription).

Manufacturer: JSC "Monfarm".

Manufacturer's address and place of business.

8, Zavodska Street, village Avramivka, Uman district, Cherkasy region, Ukraine, 19161.

Similar drugs

Brand name Dosage form Active substance / Dosage Manufacturer
PROSTATILEN suppositories, rectal PJSC "Lekhim - Kharkiv"
PROSTATILEN-ZINC suppositories, rectal PJSC "Lekhim - Kharkiv"

The original data is available in the language of the country of manufacture.

Data source: State Register of Medicinal Products of Ukraine

Data last verified: August 13, 2026